Delivery Order SPE2DB22D1106-SPE2DB25FFGF6
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,324.90. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a single transaction under the company's broader pharmaceutical supply relationship with DLA. The award was not designated as a set-aside contract and was competitively awarded. Performance of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $7,386.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for supply of Otezla 30 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $48,488.62 with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,235.58 by the Defense Logistics Agency for 60 tablets of Otezla 30 mg on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitive award utilized firm fixed pricing with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $29,588.62. This firm fixed-price delivery order, which is expected to conclude by August 15, 2025, represents a competitively awarded, non-set-aside contract with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award demonstrates the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $7,764.93 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of August 20, 2025. This competitive award, issued on August 19, 2025, carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $23,024.39. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement and is scheduled for ultimate completion by August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform all work at...
- The Defense Logistics Agency awarded a delivery order valued at $3,707.42 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Otezla 30 mg tablets (60-count units) at a firm fixed price with a ceiling value of $40,194.81 and an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing support to federal medical procurement under its larger contract vehicle. The delivery is scheduled to take place...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGF6Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Otezla 30 mg tablets in a quantity of 60 units, with a contract ceiling value of $7,352.82. This award represents a firm fixed price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The delivery order is set to be completed by September 3, 2025. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As one of the nation's major pharmaceutical distributors, AmerisourceBergen Drug Corp supplies a broad range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The Otezla tablets being procured under this delivery order represent specialty pharmaceutical products within the company's extensive portfolio of brand-name and generic medications supplied through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/2/25 |